“When examining breast implant specimens (for example, seroma, capsule, devices) for diagnostic evaluation, characterize all findings and potential diagnoses,” the FDA said.
Additionally, any findings of lymphomas, SCC, or other cancers surrounding the breast implant should be immediately reported to the FDA.
In the meantime, the agency has detailed its commitment to ensuring public safety.
“The FDA is continually evaluating the postmarket safety of approved breast implants and communicating about the risks associated with these devices. We will continue to communicate to the public on significant findings as new information and analyses become available.”
To read the FDA’s complete statement, visit the link here.
If true crime defines your free time, this is for you: join Chip Chick’s True Crime Tribe
The Terrifying True Tale Of The Real Annabelle Doll And What Her Reign Of Terror Looked Like